There's been a notable change in appetite for Carl Zeiss Meditec AG shares in the week since its yearly report, with the stock down 15% to €49.30. Revenues were €2.1b, approxi ...
Carl Zeiss Meditec has strong fundamentals and growth potential. It has impressive free cash flow and rising shareholder ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
when its stock has... Carl Zeiss Meditec AG ( ETR:AFX ), might not be a large cap stock, but it received a lot of attention from a... Carl Zeiss Meditec AG announced today that, after securing all ...
The broader Asia-Pacific region was also a weak spot, with organic growth in ophthalmology devices down 4.5% for the year, ...
View Carl Zeiss Meditec AG (CZMWY) current and estimated P/E ratio data provided by Seeking Alpha.
It is hard to get excited after looking at Carl Zeiss Meditec's (ETR:AFX) recent performance, when its stock has... Carl Zeiss Meditec AG ( ETR:AFX ), might not be a large cap stock, but it received a ...
It is hard to get excited after looking at Carl Zeiss Meditec's (ETR:AFX) recent performance, when its stock has... Carl Zeiss Meditec AG ( ETR:AFX ), might not be a large cap stock, but it received a ...
Carl Zeiss Meditec's stock continues to face significant market challenges, with shares trading at €55.70 on XETRA, marking a 1.2% decline. This downturn represents a dramatic shift from the company's ...
It is hard to get excited after looking at Carl Zeiss Meditec's (ETR:AFX) recent performance, when its stock has... Carl Zeiss Meditec AG ( ETR:AFX ), might not be a large cap stock, but it received a ...
It is hard to get excited after looking at Carl Zeiss Meditec's (ETR:AFX) recent performance, when its stock has... Carl Zeiss Meditec AG ( ETR:AFX ), might not be a large cap stock, but it received a ...